Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-06

Clinical Trial Update: Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tiagabine to enhance slow-wave sleep in adults with obstructive sleep apnea has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tiagabine (tiagabine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Sleep Apnea, Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2017-06-06